Fri, Apr 18, 2014, 7:25 AM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

evenu2canexcel 107 posts  |  Last Activity: 17 hours ago Member since: Feb 5, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • evenu2canexcel evenu2canexcel Mar 18, 2014 6:39 PM Flag

    Bump
    "Obviously, SIGA chose to defer recognition of the revenue until next fiscal quarter, which is the 1st quarter of the new fiscal year.

    SIGA now has reported $140.225 million ($30.5 million of which is invoiced to BARDA but as yet not received) in deferred revenue (and currently counted as cash in bank and offset by a deferred revenue account). While this new quarter, most likely delivered in May 2014, will result in another 250,000 courses of Arestvyr delivered to the U.S. Strategic National Stockpile. This additional revenue of $29.8 million revenue at $119.24 per avg unit revenue (cost per unit includes the free doses averaged) will be accounted for in Q3.

    Even if the margin costs per unit are amortized to be 35 percent of the cost per unit, that would mean that as of today, that mean SIGA has thus far earned $91 million in net income yet to be reported in future quarters.

    Assuming SIGA remains at 53 million shares outstanding, that means earnings of $1.72 per share will be reported next quarter, and about $19.37 million per quarter (or $0.365 / share per quarter) thereafter, assuming no new contracts are signed.

    Carrying this calculation forward for the following two quarters, that means in the coming fiscal year (of which we are already 1/5 through), SIGA will make $1.72 Q1 + $0.365 Q2 + $0.365 Q3 + $0.365 Q4 = $2.82 / share FY 2015 Ending 3/2015.

    PIP's most likely outcome will be to get 50 percent of all revenue streams in the future, but possibly not current or past earnings steams. Even if PIP were to get 50 percent of the deferred revenue and earnings, SIGA would retain rights to license Arestvyr (while PIP may also retain equal rights to license), SIGA will make at a minimum $1.41 / share in FY2015. The best case scenario will be for SIGA to get to keep most of its pre-earned revenue, and therefore will make $2.82 / share in FY 2015.

    So, right now, SIGA at a future PE of 2.6 or 1.2"

    Sentiment: Strong Buy

  • evenu2canexcel evenu2canexcel Mar 18, 2014 6:16 PM Flag

    "In March 2007, a 2-year-old Indiana boy and his mother contracted a life-threatening vaccinia infection from the boy's father.[21] The boy developed the telltale rash over 80 percent of his body after coming into close contact with his father, who was vaccinated for smallpox before being deployed overseas by the United States Army. The United States military resumed smallpox vaccinations in 2002. The child acquired the infection due to eczema, which is a known risk factor for vaccinia infection. The boy was treated with intravenous immunoglobulin, cidofovir, and an experimental drug being developed by SIGA Technologies.[22] On April 19, 2007, he was sent home with no after effects except for possible scarring of
    the skin.[21]"

    The CURE Is!
    The $2.8B Contract Still Is!
    SIGA has the only product that works(CURES) on several poxes!

    Nothing from the company NHP's(monkeys) fear & loathe has worked on NHP's or humans including the toddler when it was withdrawn from use by the female CDC MD.!
    Pray for JOSH, says the NHP's!
    Pray that the CMX product is withdrawn, says the NHP's!
    Pray that Josh's parents request the CURE, says the NHP's!
    Do you agree with the NHP's,NWAMLN?

    IMO

    Sentiment: Strong Buy

  • Thought so!
    So why did FDA approve its use on Josh?
    Hmmm?
    More politics?

    IMO

    Sentiment: Strong Sell

  • "In March 2007, a 2-year-old Indiana boy and his mother contracted a life-threatening vaccinia infection from the boy's father.[21] The boy developed the telltale rash over 80 percent of his body after coming into close contact with his father, who was vaccinated for smallpox before being deployed overseas by the United States Army. The United States military resumed smallpox vaccinations in 2002. The child acquired the infection due to eczema, which is a known risk factor for vaccinia infection. The boy was treated with intravenous immunoglobulin, cidofovir, and an experimental drug being developed by SIGA Technologies.[22] On April 19, 2007, he was sent home with no after effects except for possible scarring of
    the skin.[21]"

    The CURE Is!

    Nothing from the company NHP's(monkeys) fear & loathe has worked on NHP's or humans including the toddler when it was withdrawn from use by the female CDC MD.!
    Pray for JOSH, says the NHP's!
    Pray that the CMX product is withdrawn, says the NHP's!
    Pray that Josh's parents request the CURE, says the NHP's!
    Do you agree with the NHP's,NWAMLN?

    IMO

    Sentiment: Strong Buy

  • Reply to

    4300 shares all morning

    by drod4ball Mar 17, 2014 10:42 AM
    evenu2canexcel evenu2canexcel Mar 17, 2014 10:51 AM Flag

    "What a POS"

    Stealing GOSCHLONG's words?
    Oh, that's right,you & GOSCHLONG are the same DOPE!

    NWAMLN?

    IMO

    Sentiment: Strong Buy

  • evenu2canexcel evenu2canexcel Mar 17, 2014 10:00 AM Flag

    " So says the Uniform Commercial Code."
    Parsons knew that & passed for a fantasy cuz he knew the SC would conclude if the UCC, no need for the CC,NWAMLN?

    SC ordered CC to develop expectancy damages if relevant & possible not specific performance.
    Parsons already concluded expectancy damages were not possible to develop.
    You want Parsons to be cute?
    And be berated AGAIN by the SC?
    Not likely,NWAMLN?

    IMO

    Sentiment: Strong Buy

  • evenu2canexcel evenu2canexcel Mar 17, 2014 7:19 AM Flag

    " The court, therefore, has expressed doubt about whether such new evidence will ultimately be relevant to its decision on the damage award. "

    Especially since Parsons devoted 28 pages as to why he was unable to determine expectancy damages
    at the time of the "alleged breach",NWAMLN?

    No expectancy damages?
    What to do?
    Reliance damages at the time of the "alleged breach"?
    One buck($1)?
    Two months to pull one out of his hat?

    Watch and enjoy.......FLIX!

    IMO

    Sentiment: Strong Buy

  • Hint 1.!

    Their NHP's(monkeys) died when treated with their product & the CDC MD. took the toddler off their product
    & treated him with the CURE (which CURED him & resulted in a tiny startup small business being awarded
    a $2.8B contract).

    Hint 2.! Their PPS plummetted from $20+ to $12+ within weeks of their IPO!

    Hint 3.! They have succeeded playing the "grants game"( contributing to politicians to obtain grants, then paying speaking fees, consulting fees to those politicians to influence them to get additional grants to use for
    additional contributions, fees,etc)!

    I bet you know by now, NWAMLN?

    IMO

    Sentiment: Strong Buy

  • Reply to

    $3.10 after the 3/10 call...

    by brooklynj36 Mar 4, 2014 12:32 PM
    evenu2canexcel evenu2canexcel Mar 12, 2014 9:54 AM Flag

    Another phoney ID from DOPEYDROD exposed?
    You betcha.
    The DOPE is posting here with at least 6 ID's & holds no shares & never did.
    Note: the guy "holding in the red" never posts a sentiment next to "Sentiment"!
    That's the tipoff to all fo his aliases paid to bash 24/7 for $12/hour as a DULLPITCHFORK,NWAMLN?

    IMO

    Sentiment: Strong Buy

  • Josh to be test subject No. 1 of 20 subjects.
    All the U.S. praying for Josh but the NHP's know that the product did not cure them when they were infected.
    Could a combo of the CURE & their product cure Josh?
    Hmmm?

    IMO

    Sentiment: Strong Buy

  • evenu2canexcel evenu2canexcel Mar 11, 2014 10:25 AM Flag

    If smallpox were to be released on a subway in New York, the effects would be devastating," Hruby said. "Except for the military, people aren't getting vaccinated anymore ... we're very vulnerable."

    Siga created the drug with plans to market it to the government. The company hopes the government will stockpile ST-246 for use in emergency situations. According to those close to him, Hruby remains modest and unassuming, despite his recent success.

    "He is still the same guy I go fishing with," said Peter Bottomley, an OSU microbiology professor who has been a colleague and a friend to Hruby for more then 20 years. "He hasn't let any of it go to his head."

    Hruby said he has no plans to leave OSU, and will remain committed to the university for years to come."

    The CURE Is!
    The contract(s) is!

    That other company cannot make the same claims & fears negative exposure if Josh is treated & is NOT cured,NWAMLN?

    IMO

    Sentiment: Strong Buy

  • evenu2canexcel evenu2canexcel Mar 11, 2014 10:20 AM Flag

    "It was designed as an oral medication, and there was no way this child could have taken anything by mouth," Hruby said. "So we had to be creative."

    In the end they decided to open the capsule, emulsify its contents, and deliver it through the child's feeding tube.

    "The medicine had been tested in humans for safety, but it had never been in a child or a diseased person before," Hruby said. "We had to use our best judgment as far as dosage was concerned."

    The child received his first dose of ST-246 by 9 a.m. Sunday morning, showing marked improvement almost immediately.

    Health officials remained in constant contact with Hruby, closely monitoring the child for changes and scrutinizing lab results.

    "We were having daily phone calls with as many as 50 people on the phone," Hruby said.

    With 25 years experience in pox viruses, Hruby is an expert in his field. He founded Siga Technologies in 1996, a flourishing biotechnology company with locations in both New York and Corvallis.

    The company designs and develops products for the prevention and treatment of a myriad of infectious diseases, including broad spectrum antibiotics designed to quash antibiotic resistant infections.

    "We're doing a lot of exciting things right now, like our work in hemorrhagic fever viruses [such as ebola, lassa fever]," Lehew said. "And of course, smallpox."

    Officially eradicated in 1977, the last known samples of smallpox are purported to be located at the CDC headquarters in Atlanta and a research facility in Russia.

    This assertion is contested by Hruby, who cites the looming threat of bioterrorism as the chief motivator in the development of ST-246.

    "During the Cold War, the Soviet Union was developing smallpox to use as a weapon. After the break up of the SU, thousands of scientists were suddenly out of work and nobody knows where they all went... or what happened to all the missing samples."

    Hruby is concerned that samples could fall into the wrong hands.
    (cont'd)

    Sentiment: Strong Buy

  • evenu2canexcel evenu2canexcel Mar 11, 2014 10:17 AM Flag

    The father was supposed to leave for duty, but I guess he was granted an unexpected furlough," Hruby said.

    "So this guy had just gotten the smallpox vaccine, then he went home to visit with his family. Well the virus used in that vaccine, vaccinia, normally sheds from the site of inoculation for a couple weeks."

    Apparently still shedding from the injection site, the father ventured home, unknowingly exposing his family to the vaccinia virus.

    "People receiving the smallpox vaccination are supposed to avoid contact with children, people with cuts, or the otherwise immunocompromised," Hruby said. "And as it turns out, the boy already suffered from eczema. So with all those open sores, it's no wonder he contracted Vaccinia."

    The boy had suffered from severe health problems throughout his life -- including eczema, a skin disease. Skin lesions, like those caused by eczema, can make individuals more susceptible to infection.

    CDC officials questioned Hruby about Siga's newest drug development, in the hopes that it would help save the dying boy. Still in the experimental phase, ST-246 is an oral anti-viral medication designed to combat smallpox.

    The virus used in smallpox vaccinations, the vaccinia virus, is structurally similar to the smallpox virus. So theoretically, a drug designed to defeat smallpox would also work against vaccinia, and vice versa.

    "They explained the situation to me ... we discussed it ... and in the end, we decided to give it a go," Hruby said. "Then the CDC got a teleconference with the FDA. We told them what we were going to do, and they granted permission."

    Officials arranged for a private charter plane to immediately transport Hruby and his life saving cargo. The redeye flight departed from Oregon on Saturday night and landed in Chicago around 3 a.m. Sunday morning. From there, Hruby traveled to the hospital and met with pharmacy staff to discuss the logistics of administering ST-246.
    (cont'd)

    Sentiment: Strong Buy

  • am with Oregon State U. ties uses new drug to save toddler

    SIGA
    $3.43
    -0.15 -4.2%

    Released : Friday, June 08, 2007 4:35 PM

    CORVALLIS, Ore., Jun 08, 2007 (OSU Daily Barometer, U-WIRE via COMTEX) -- In March 2007, a 2-year-old
    a boy lay dying in a Chicago hospital bed, stricken with a rare affliction not seen since the 1990s. Known
    treatment avenues had failed, leaving doctors skeptical about the toddler's chances for recovery.

    In addition to other signs and symptoms, the boy developed a severe systemic skin reaction that rendered him virtually unrecognizable. The rash, typical of eczema vaccinatum, blanketed the toddler's body in a harrowing shroud of purple sores and bloody skin.

    Desperate to save a life not fully lived, health care officials sought out promising new drug -- ST-246. The experimental drug, never before tested in children, was immediately airlifted from Oregon and was promptly administered in solute form.

    To the collective relief of everyone involved, the boy's condition improved quickly.

    Thanks to SIGA Technologies Inc. and ST-246, the boy who wasn't expected to make it through the weekend was discharged April 19.

    He is expected to experience some permanent scarring due to the severity of the skin reaction, but will otherwise make a full recovery.

    "It was the most terribly exciting, terribly frightening thing I've ever been a part of," said Oregon State University faculty member Dennis Hruby, a 1973 OSU graduate and Chief Scientific Officer at Siga.

    OSU graduate Melissa Lehew, executive assistant and officer manager at Siga, described the experience as nerve-wracking.

    "We were all on the edge of our seats," Lehew said. "It was a stressful time."

    Hruby, a leading pox specialist, was contacted by the Centers for Disease Control one Saturday afternoon in March. Officials debriefed him on the unique case of a boy who developed eczema vaccinatum after visiting with his father, an Iraq-bound soldier recently vaccinated for smallpox.

    (cont'd)

    Sentiment: Strong Buy

  • Reply to

    Siga $3.15 AH

    by golongin2008 Mar 10, 2014 5:38 PM
    evenu2canexcel evenu2canexcel Mar 10, 2014 6:45 PM Flag

    The actual trades:
    DOPEY sold 100 shares at $3.15, NWAMLN?

    6:44 $ 3.15 Low 100
    16:32 $ 3.36 1,000
    16:23 $ 3.40 High 9
    16:10 $ 3.3736 200
    16:06 $ 3.3799 300

    IMO

    Sentiment: Strong Buy

  • Reply to

    Siga $3.15 AH

    by golongin2008 Mar 10, 2014 5:38 PM
    evenu2canexcel evenu2canexcel Mar 10, 2014 6:39 PM Flag

    "On 1600 shares....LOL..."
    Dopey & can't read.
    $3.15 on 100 shares, DOPEY!

    IMO

    Sentiment: Strong Buy

  • Reply to

    Bashers' Rules-FYI

    by evenu2canexcel Jan 7, 2014 10:16 AM
    evenu2canexcel evenu2canexcel Mar 10, 2014 5:28 PM Flag

    Bumped by popular demand.
    Review the rules & see if you can ID our resident bashers & their ID's from the rules, starting with DOPEYDROD, the fictionally bagged mental midget posting for $12/hour as a DULLPITCHFORK.
    IMO

    Sentiment: Strong Buy

  • evenu2canexcel evenu2canexcel Mar 10, 2014 3:39 PM Flag

    For 28 pages in his opinion, Parsons lamented that he could not reasonably award expectancy damages.
    So what to do now?
    Reliance damages?
    $1?
    Could be.
    Watch for & read Parsons' squirming screed & enjoy?
    Also a could be.IMO

    Sentiment: Strong Buy

  • Reply to

    A One Flix Pony?

    by evenu2canexcel Oct 28, 2013 8:59 AM
    evenu2canexcel evenu2canexcel Mar 6, 2014 10:04 AM Flag

    NO WAY!
    Another 52 week high today as all await stock split, a quick double & a buyout?

    Watch & be a bystander!

    But buy a few SIGA, TAKE DELIVERY, box 'em, be patient. or regret you did not.......whenever!

    IMO

    Sentiment: Strong Buy

  • Reply to

    Bashers' Rules-FYI

    by evenu2canexcel Jan 7, 2014 10:16 AM
    evenu2canexcel evenu2canexcel Mar 4, 2014 2:09 PM Flag

    Bumped by popular demand.

    Review the rules & see if you can ID our resident bashers & their ID's from the rules, starting with DOPEYDROD, the fictionally bagged mental midget posting for $12/hour as a DULLPITCHFORK.

    IMO

    But buy a few SIGA, TAKE DELIVERY, box 'em, be patient & be grateful that you did ........whenever!

    Sentiment: Strong Buy

SIGA
2.79-0.01(-0.36%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST